Suicide/
Violence
+
Following an adverse plaintiff’s verdict in 2001 that triggered additional lawsuits, GSK retained K&S to defend against claims that Paxil caused patients to harm themselves or others.
Discontinuation
+
Litigation triggered by plaintiffs’ lawyers learning of complaints about symptoms said to occur after discontinuing Paxil and other antidepressants and a subsequent labeling change.
Pregnancy
+
Litigation was triggered by a pregnancy-category change in FDA labeling/prescribing classification, and scientific research into a potential antidepressant/birth defect connection.
